Download 20151126_Chlamydia_Azithro_CP_V2

LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD)
FOR SUPPLY OF
AZITHROMYCIN FOR THE TREATMENT OF
UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS
BY
COMMUNITY PHARMACISTS WORKING IN A COMMUNITY
PHARMACY CONTRACTED BY [NAME OF LOCAL
AUTHORITY]
Version Number 2
Change History
VERSION 2
New template.
Updated SPC/BNF/NICE and other references
Amendments in line with BASHH guidelines (2015)
Organisations
Each organisation using this PGD must ensure that it is formally authorised by a pharmacist,
a medical lead and a governance lead on behalf of the authorising organisation to ensure
that this document meets legal requirements for a PGD.
Community pharmacists
Each community pharmacist using this PGD must ensure that it is formally authorised by a
pharmacist, a medical lead and the governance lead on behalf of the authorising
organisation to ensure this document meets legal requirements of a PGD
This PGD must only be used by registered community pharmacists who have been named
and authorised to do so. This will be a locally agreed arrangement between the
commissioner and the provider.
The most recent and in date final signed version of the PGD must be used.
Pharmacists are responsible and accountable for ensuring that they work under the relevant
PGD and correct Service Specification applicable to the area, and commissioner, where they
are working.
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 1 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
TABLE OF CONTENTS
CONTENTS
PGD for the supply of azithromycin
PAGE NUMBER
1-15
Staff Characteristics
11-12
Authorisation and Signatures
To be added by approving
organisation
Individual authorisation to supply azithromycin using
this PGD
To be added by approving
organisation
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 2 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
AZITHROMYCIN 250 mg CAPSULES OR TABLETS or
AZITHROMYCIN 500 mg CAPSULES OR TABLETS
CLINICAL CONDITION
TO WHICH THIS
DIRECTION APPLIES
INCLUSION CRITERIA

Uncomplicated genital Chlamydia trachomatis infection

Individuals with a definite or equivocal diagnosis of Chlamydia
trachomatis
Sexual contacts of individuals with chlamydia evidenced by
contact slip, text message or other written confirmation
Re-treatment of individual who has had sexual intercourse
within 7 days of receiving treatment for the above condition in
the same pharmacy or who has had sex with a partner
untreated for the above condition
Re-treatment of an individual who has been treated with
azithromycin in the same pharmacy for the above indications
but has vomited the dose within 3 hours of taking the
medication




EXCLUSION CRITERIA
(I.E. SITUATIONS NOT
COVERED BY THE
PGD)
Personal Characteristics




Individuals aged under 15 years of age
Individuals aged under 16 years who are assessed as not
competent using Fraser Guidelines
Individuals aged 16 years of age and over and not competent
to consent
Individual known to have co-existing untreated gonorrhoea
and chlamydia
Medical history
 Males with epididymitis and testicular pain
 Males with dysuria and urethral discharge
 Females with pelvic pain or symptoms of Pelvic Inflammatory
Disease (PID)
 Severe hepatic impairment
 Severe renal impairment
 Current/past history of cardiac rhythm or conduction
disturbance
 Presence of concomitant conjunctivitis and/or joint
pain/swelling
 Acute porphyria
See next page
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 3 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
EXCLUSION CRITERIA
(I.E. SITUATIONS NOT
COVERED BY THE
PGD)
Continued from previous page
Medical history



Myasthenia gravis
Known or suspected pregnancy
Breastfeeding
Medication history


CAUTIONS/NEED FOR
FURTHER
ADVICE/ACTION TO BE
TAKEN
ACTION IF EXCLUDED

Choice of therapy: the treatments in this PGD template are
written according to national guidance; however the pharmacist
should also refer to the local formulary or other local supporting
guidance for selection of the most appropriate preparation.

Some brands of azithromycin contain soya or soya lecithin
and are therefore contraindicated in individuals with an allergy
to soya or peanuts. If individual is allergic, check
manufacturer’s information for brand being used and if
necessary, exclude from PGD or select an alternative suitable
brand if available.

If allergic to azithromycin, consider doxycycline as a
alternative treatment
Refer to sexual health services as soon as possible with
information about further options
Explain reasons for exclusions with individual and refer to
appropriate services
For young people, consider if safeguarding action is needed
Document all actions taken in the relevant patient record




ACTION IF PATIENT
DECLINES
TREATMENT
Interacting medicines – Check Appendix 1 of current British
National Formulary (BNF)
Known allergy or hypersensitivity to macrolide antibiotics or
any constituent of the medication
 Make individual aware of the need for treatment and refer to
relevant sexual health provider/GP/urgent care
 Record the refusal in the relevant patient record
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 4 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
DRUG DETAILS
NAME, FORM &
STRENGTH OF
MEDICINE
ROUTE/METHOD

LEGAL CATEGORY
Prescription Only Medicine (POM)
USE OUTSIDE THE
TERMS OF THE
MARKETING
AUTHORISATION
Best practice advice given by the British Association for Sexual
Health and HIV (BASHH) is used for guidance in this PGD
template and may vary from the Summary of Product
Characteristics (SPC)
Azithromycin 250 mg or 500 mg capsules or tablets
Oral
Children under 16 years or under 45kg weight
No brand of azithromycin tablets or capsules is licensed for use in
those aged under 16 years and/or weighing under 45 kg.
This unlicensed use is supported by the BNF for Children (BNFC)
which states that children aged 12 to 18 years of age may receive
a single dose of 1g azithromycin.
Individuals must be informed that the medicine is being given
outside the terms of the SPC and given the option of seeing a
doctor/ independent non-medical prescriber.
QUANTITY
250 mg capsules or tablets (x4)
or 500 mg capsules or tablets (x2)
DOSAGE/FREQUENCY
1g as a single dose, ideally taken as directly observed therapy
DURATION OF
TREATMENT
MAXIMUM OR
MINIMUM TREATMENT
PERIOD
Single dose for immediate self administration
Single dose for immediate self administration
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 5 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
SIDE EFFECTS
Any drug may produce
unwanted or unexpected
adverse reactions.
Detection and recording
of these is of vital
importance. Patients
should be actively
encouraged to report
any suspected adverse
reaction, particularly to
black triangle medicines.
Refer to current Summary of Product Characteristics (SPC) of
relevant product and current British National Formulary (BNF) for
further information.
This list may not represent all reported side effects of this
medicine.
Common
Nausea
Vomiting
Diarrhoea
Anorexia,
Dyspepsia





Less common
 Dizziness
 Headache,
 Drowsiness
 Abdominal discomfort (pain/cramps)
Rare
 Allergic reactions including angioneurotic oedema
 Photosensitivity
 Arthralgia
 Hepatitis and cholestatic jaundice
 Interstitial nephritis and renal failure
 Constipation
 Paraesthesia
 Tinnitus
 Insomnia
 Syncope
 Convulsions and taste disturbances
In the event of untoward or unexpected adverse reactions:
 If necessary seek appropriate emergency advice and
assistance
 Document in the individual’s clinical record and inform
appropriate doctor/independent nurse prescriber
 Complete incident procedure if adverse reaction is severe
(refer to local organisational policy)
 Use yellow card system to report serious adverse drug
reactions directly to the Medicines and Healthcare products
Regulatory Agency (MHRA). Yellow cards are available in the
back of the BNF or obtained via Freephone 0808 100 3352 or
online at www.yellowcard.mhra.gov.uk.
 The public can report adverse effects directly to the MHRA via
the yellow card scheme and should be encouraged to do so.
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 6 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
ADVICE TO
INDIVIDUAL

Provide Manufacturer’s Patient Information (PIL) and discuss


Verbal and written information on Chlamydia trachomatis
Explain mode of action, side effects, and benefits of the
medicine
Azithromycin tablets can be taken at any time in relation to
food but there should be a gap between taking the tablets and
antacids


Azithromycin capsules should be taken one hour before or
two hours after food or antacids

If vomiting occurs within 3 hours of taking capsules/tablets
offer option of repeat dose of azithromycin (under PGD) or
refer to sexual health service provider

Abstain completely from sexual contact (even with a condom)
for 7 days after treatment and for 7 days after partner(s)
treated

Warn that if sexual contact takes place after treatment with an
un-treated partner there is a risk of re-infection.

Discuss implications of incomplete/untreated infection of self or
partner

Ensure partner notification has taken place and document.

Offer condoms and advice on safer sex practices and possible
need for testing for sexually transmitted infections (STIs)

Ensure the individual has contact details of local contraceptive
/sexual health services
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 7 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
FOLLOW UP



RECORDS
Follow local protocol for chlamydia follow up and partner
notification
Individuals with chlamydia who have not had a full STI screen
(or who did not have chlamydia diagnosed in a sexual health
clinic) should be referred to a sexual health clinic for a full STI
screen
Individuals age under 25 years should be offered a repeat
chlamydia test 3 to 6 months after treatment because of the
high risk of re-infection
The authorised community pharmacist must ensure the following
is documented in the individual’s medical record:






















Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Individual’s name, address and date of birth
GP contact details if registered
Attendance date
Reason for attendance
Relevant past and present medical history, including drug
history
Any known allergy
The consent of the individual
If individual is under 15 years of age, record action taken
If individual is under 16 years of age document competency
using Fraser guidelines
If individual is aged 16 years of age and older and not
competent to consent, record action taken.
Relevant symptoms (where appropriate)
Inclusion or exclusion from PGD
A statement that supply or administration is by using a PGD
Advice given about the medication including side effects,
benefits, and when and what to do if any concerns
Details of any adverse drug reactions and what action taken
Any administration outside the terms of the marketing
authorisation
Record the name/brand, dose of the medication and quantity
supplied
Record batch number and expiry date according to local policy
or national guidelines
Any referral arrangements
Record follow up and/or signposting arrangements
Any other relevant information that was provided to the
individual
Name and signature (which may be an electronic signature) of
the community pharmacist supplying the medicine)
Expiry date: 26/11/2018
Reference Number :
Page 8 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
REFERENCES

Manufacturers’ Summaries of Product Characteristics (SPC)
This list may not be comprehensive. This PGD does not restrict
which brands can be supplied.
See http://www.mhra.gov.uk/spc-pil/ or
http://www.medicines.org.uk for further information.

Azithromycin film coated tablets 250mg, Sandoz Limited
Last updated: 31.05.15
Accessed 27.10.15
https://www.medicines.org.uk/emc/medicine/26131

Azithromycin film coated tablets 500mg, Sandoz Limited
Last updated: 06.08.13
Accessed 27.10.15
https://www.medicines.org.uk/emc/medicine/21720

Azithromycin 250mg film-coated tablets. Actavis UK Ltd.
Last updated: 25.07.13
Accessed 27.10.15
https://www.medicines.org.uk/emc/medicine/27825
(250mg)

Azithromycin 500mg film-coated tablets. Actavis UK Ltd.
Last updated: 25.07.13
Accessed 27.10.15
https://www.medicines.org.uk/emc/medicine/27576

Clamelle tablets ® (Azithromycin 500mg). Actavis UK Ltd.
Last updated: 21.11.13 Accessed: 27.10.15
https://www.medicines.org.uk/emc/medicine/24273

Zithromax 250 capsules ® (Azithromycin 250mg). Pfizer
Limited
Last updated: January 2015 Accessed: 27.10.15
https://www.medicines.org.uk/emc/medicine/1477

Joint Formulary Committee. British National Formulary
(online)
London: BMJ Group and Pharmaceutical Press
Accessed via <http://www.medicinescomplete.com> on
15/02/15

National Institute for Health and Care Excellence (2013).
Patient Group Directions. Medicines Practice Guidelines 2
http://www.nice.org.uk/guidance/MPG2
See next page
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 9 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
References
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Continued from previous page

British Association for Sexual Health and HIV (BASHH)
(2015) UK National guideline for the management of
infection with Chlamydia trachomatis (2015)
http://www.bashh.org/documents/2015_UK_guideline_for_th
e_management_of__Chlamydia_trachomatis_final_12....pdf

British Association for Sexual Health and HIV (2013) Retesting of young persons diagnosed with chlamydia infection
http://www.bashh.org/documents/Retesting%20of%20young
%20peoplediagnosed%20with%20chlamydia%20(Sep%202
013).pdf
Expiry date: 26/11/2018
Reference Number :
Page 10 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
STAFF CHARACTERISTICS
The named community
pharmacist authorised to
supply and/or administer
medications under the
PGD must meet the
following criteria:
THE COMMUNITY PHARMACIST MUST BE AUTHORISED
BY NAME, UNDER THE CURRENT VERSION OF THIS PGD
BEFORE WORKING ACCORDING TO IT
Registration
The community pharmacist must be registered with the General
Pharmaceutical Council (GPhC) or Pharmaceutical Society of
Northern Ireland (PSNI)
Specialist qualifications and competencies
 Has successfully completed the CPPE PGD e-learning
programme or can provide evidence that they have achieved
the competency levels specified in NICE Competency
Framework for Health Professionals using Patient Group
Directions
http://www.nice.uk/mpc/goodpracticeguidance/GPG2.jsp
 Has had the training which enables them to make a clinical
assessment in order to establish the sexual health need
and supply the medicine according to this PGD
 Can satisfy the requirements of self-declaration of
qualifications and competence to deliver sexual health
services according to the CPPE Programmes for
o Sexual health in pharmacies (CPPE 2015)
o Safeguarding children and vulnerable adults
o Consultation skills for pharmacy practice: taking a
patient-centred approach
o Chlamydia screening and treatment
o Contraception
o Emergency contraception (2015)
or
Can provide evidence of competencies achieved through
other local training which delivers the equivalent knowledge.

Pharmacists must ensure that the pharmacy where they are
providing the service is contracted for this service

Have a current contract of employment with (insert name of
organisation here)
See next page
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 11 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
STAFF
CHARACTERISTICS
The named community
pharmacist authorised to
supply and/or administer
medications under the
PGD must meet the
following criteria:
Continued from previous page
Maintenance of competencies

Has demonstrated that they are competent to provide the
service

The pharmacist should be aware of any changes to the
recommendations for this medication

Is familiar with current BASHH guidelines on Chlamydia
trachomatis
An up to date list and signatures of registered community pharmacists who are authorised to
practise under this PGD is kept in
by
Practitioners not listed are not authorised to practise under this PGD.
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 12 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
PGD DEVELOPMENT GROUP
Date PGD template comes into effect:
Review date
26/11/2015
26/05/2018 or earlier in the light of
significant changes in best practice
26/11/2018
Expiry date:
This template was peer reviewed and ratified by London Contraception and Sexual Health
PGD Working Group:
NAME/ROLE
Kathy French
Chair - Working Group
Angela Bussey
Advisor - Working Group
POSITION
DATE
Project Lead
Independent Nurse Advisor
SRHC, Project Lead
25/11/2015
Principal Pharmacist
Medicines Information
Projects.
Guy’s and St Thomas’ NHS
Foundation Trust.
26/11/2015
Lead Medical Consultant
Dr Nneka Nwokolo
25/11/2015
Consultant Physician
GUM/HIV
Chelsea and Westminster NHS
Hospital Foundation Trust
Lead Pharmacist
Josie Mansell
Community Health Services 25/11/2015
Pharmacist
Guy’s and St Thomas’ NHS
Foundation Trust.
Lead Community Pharmacist
Reviewer
Community Pharmacist
Chair Brent & Harrow LPC.
25/11/2015
Shabbir Panju
Specialist reviewers
Rosie Jackson
Marielle Perraut
Head of Nursing - Women’s and Sexual Health,
Lewisham and Greenwich NHS Trust
Matron, Sexual and Reproductive Health, Guy’s
and St Thomas’ NHS Foundation Trust
The PGD template is not legally valid until it has had the relevant organisational
approval.
See next page.
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 13 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
ORGANISATIONAL AUTHORISATIONS AND OTHER LEGAL REQUIREMENTS
This page may be deleted if replaced with a format agreed according to local PGD policy with
relevant approvals and authorisation.
The PGD is not legally valid until it has had the relevant organisational authorisations.
To ensure compliance with the law, organisations must add local authorisation details i.e.
clinical authorisations and the person signing on behalf of the authorising organisation.
You may either complete details below or delete and use a format agreed according to local
PGD policy which complies with PGD legislation and NICE MPG2 PGD 2013.
Name
Job title and
organisation
Signature
Date
Senior doctor
Senior pharmacist
Senior representative of
professional group using
the PGD e.g. Lead
Community pharmacist
(Optional but best practice)
Lead Specialist Reviewer
e.g. microbiology* if relevant
Person signing on behalf of
authorising body
E.g. Director of Public
Health on behalf of a local
authority or clinical
governance lead on behalf
of an NHS Trust.
Whilst this PGD is written according to national guidance such as BASHH, NICE PGD
Guidelines recommend that each organisation ensures that a local antimicrobial specialist or
antimicrobial stewardship committee lead is involved in its approval and local adoption
It is the responsibility of the authorising organisation to ensure that all legal and governance
requirements for authorising the PGD.
It is the responsibility of the provider organisation to ensure that all legal and governance
requirements for using the PGD are met.
To meet legal requirements, authorising organisations must add an Individual Practitioner
Authorisation sheet or List of Authorised Practitioners. This varies according to local policy
and how the service is managed but this should be a signature list or an individual
agreement. See next page
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 14 of 15
LONDON CONTRACEPTION AND SEXUAL HEALTH
PATIENT GROUP DIRECTION (PGD) TEMPLATE
(add organisational logo)
PATIENT GROUP DIRECTION (PGD) FOR SUPPLY OF AZITHROMYCIN FOR THE TREATMENT
OF UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS BY COMMUNITY PHARMACISTS
PGDs do not remove inherent professional obligations or accountability. It is the
responsibility of each professional to practice only within the bounds of their own
competence and in accordance with the General Pharmaceutical Council, Standards of
Conduct Ethics and Performance. Individual practitioners must declare that they have read
and understood the Patient Group Direction and agree to supply/administer medicines listed
only in accordance with the PGD.
Pharmacists are responsible and accountable for ensuring that they work under the relevant
PGD and correct Service Specification applicable to the area, and commissioner, where they
are working. (See page one)
Version No: 2
Approving Organisation Name:
Approval Committee Name:
Date of authorisation:
Expiry date: 26/11/2018
Reference Number :
Page 15 of 15